Utilization Software System News Today

CE mark reinforces the Zio monitor system as a leading innovation in ambulatory cardiac monitoring and highlights the company’s commitment to providing the highest quality product and services globally

CE mark reinforces the Zio monitor system as a leading innovation in ambulatory cardiac monitoring and highlights the company’s commitment to providing the highest quality product and services...

IRhythm is launching its next generation long-term ambulatory cardiac monitor in the U.S. 

26.09.2023 - iRhythm is launching its next generation long-term ambulatory cardiac monitor in the U.S.Zio monitor builds on the high performance of Zio XT that, together with its enhanced Zio long term continuous cardiac monitoring service, provides an elevated ... Seite 1

IRhythm is launching its next generation long-term ambulatory cardiac monitor in the U.S.Zio® monitor builds on the high performance of Zio® XT that, together with its enhanced Zio® long term...

IRhythm Technologies, Inc. today announced the U.S. launch of its next-generation Zio® monitor and enhanced Zio® long-term continuous mon

The companies announced the sleep technology platform at HLTH 2022 on Sunday.

Developed in partnership with Verily, the Zio Watch and the ZEUS System combine to create a clinical grade watch to detect and characterize AFib and integrate with clinician’s workflow 

Th FDA granted another 510(k) clearance to iRhythm Technologies for its AI-powered software system designed for use with Verily’s irregular pulse tracking watch. The clearance is for an algorithm that categorizes patients’ AFib by analyzing how much of it they experience over time.

The latest clearance is for an algorithm that characterizes how much atrial fibrillation a patient is experiencing over time.